Literature DB >> 2186772

Adjuvant chemotherapy for early breast cancer.

I C Henderson1.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2186772      PMCID： PMC1971592          DOI： 10.1038/bjc.1990.147

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  18 in total

1.  Editorial: Major advance in breast-cancer therapy.

Authors:  J F Holland
Journal:  N Engl J Med       Date:  1976-02-19       Impact factor: 91.245

2.  A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.

Authors:  P R Rosen; S Groshen; P E Saigo; D W Kinne; S Hellman
Journal:  J Clin Oncol       Date:  1989-03       Impact factor: 44.544

3.  The concept of an overview of cancer clinical trials with special emphasis on early breast cancer.

Authors:  R D Gelber; A Goldhirsch
Journal:  J Clin Oncol       Date:  1986-11       Impact factor: 44.544

4.  Breast cancer therapy: exercising all our options.

Authors:  V T De Vita
Journal:  N Engl J Med       Date:  1989-02-23       Impact factor: 91.245

5.  Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer.

Authors:  J L Haybittle; D Brinkley; J Houghton; R P A'Hern; M Baum
Journal:  BMJ       Date:  1989-06-17

6.  Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer.

Authors:  B Fisher; E R Fisher; C Redmond
Journal:  J Clin Oncol       Date:  1986-06       Impact factor: 44.544

7.  Systemic therapy in resectable breast cancer.

Authors:  G Bonadonna; P Valagussa
Journal:  Hematol Oncol Clin North Am       Date:  1989-12       Impact factor: 3.722

8.  Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience.

Authors:  B Fisher; C Redmond; D L Wickerham; D Bowman; H Schipper; N Wolmark; R Sass; E R Fisher; P Jochimsen; S Legault-Poisson
Journal:  J Clin Oncol       Date:  1989-05       Impact factor: 44.544

9.  West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. I. Patients with involved axillary lymph nodes.

Authors:  J M Morrison; A Howell; K A Kelly; R J Grieve; I J Monypenny; R A Walker; J A Waterhouse
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

10.  West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. II. Patients without involved axillary lymph nodes.

Authors:  J M Morrison; A Howell; K A Kelly; R J Grieve; I J Monypenny; R A Walker; J A Waterhouse
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.